These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3944636)

  • 1. In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies.
    Bullard DE; Adams CJ; Coleman RE; Bigner DD
    J Neurosurg; 1986 Feb; 64(2):257-62. PubMed ID: 3944636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.
    Bourdon MA; Coleman RE; Blasberg RG; Groothuis DR; Bigner DD
    Anticancer Res; 1984; 4(3):133-40. PubMed ID: 6465851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
    Bullard DE; Wikstrand CJ; Humphrey PA; Lee YS; Coleman RE; Zalutsky M; Bigner DD
    Nuklearmedizin; 1986 Dec; 25(6):210-5. PubMed ID: 3808960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.
    Zalutsky MR; Moseley RP; Coakham HB; Coleman RE; Bigner DD
    Cancer Res; 1989 May; 49(10):2807-13. PubMed ID: 2469537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
    Lee Y; Bullard DE; Humphrey PA; Colapinto EV; Friedman HS; Zalutsky MR; Coleman RE; Bigner DD
    Cancer Res; 1988 May; 48(10):2904-10. PubMed ID: 2452014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
    Lee YS; Bullard DE; Zalutsky MR; Coleman RE; Wikstrand CJ; Friedman HS; Colapinto EV; Bigner DD
    Cancer Res; 1988 Feb; 48(3):559-66. PubMed ID: 2446747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration.
    Lee YS; Bullard DE; Wikstrand CJ; Zalutsky MR; Muhlbaier LH; Bigner DD
    Cancer Res; 1987 Apr; 47(7):1941-6. PubMed ID: 3815382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma.
    Schold SC; Zalutsky MR; Coleman RE; Glantz MJ; Friedman AH; Jaszczak RJ; Bigner SH; Bigner DD
    Invest Radiol; 1993 Jun; 28(6):488-96. PubMed ID: 7686539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
    Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
    Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice.
    Colapinto EV; Lee YS; Humphrey PA; Zalutsky MR; Friedman HS; Bullard DE; Bigner DD
    Br J Neurosurg; 1988; 2(2):179-91. PubMed ID: 3267302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy.
    Blasberg RG; Nakagawa H; Bourdon MA; Groothuis DR; Patlak CS; Bigner DD
    Cancer Res; 1987 Aug; 47(16):4432-43. PubMed ID: 3607773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
    Schuster JM; Garg PK; Bigner DD; Zalutsky MR
    Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model.
    Wikstrand CJ; McLendon RE; Carrel S; Kemshead JT; Mach JP; Coakham HB; de Tribolet N; Bullard DE; Zalutsky MR; Bigner DD
    J Neuroimmunol; 1987 May; 15(1):37-56. PubMed ID: 3571486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
    Yordanov AT; Hens M; Pegram C; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2007 Feb; 34(2):173-83. PubMed ID: 17307125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
    Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
    Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.
    Zalutsky MR; Moseley RP; Benjamin JC; Colapinto EV; Fuller GN; Coakham HP; Bigner DD
    Cancer Res; 1990 Jul; 50(13):4105-10. PubMed ID: 2162252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimaging of human glioma xenografts with 123I labeled monoclonal antibody G-22 against glioma-associated antigen.
    Yoshida J; Mizuno M; Inoue I; Wakabayasi T; Sugita K; Seo H; Chiba K
    J Neurooncol; 1990 Jun; 8(3):221-9. PubMed ID: 2358855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human gliomas radioimmunoimaging with 131-I BC-2 murine IgG: preliminary report.
    Lastoria S; Castelli L; Vergara E; Seccamani E; Bonino C; Mariani M; De Santi MS; De Simone A; Ambrosio A; Zardi L
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):173-6. PubMed ID: 2092114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent.
    Reist CJ; Bigner DD; Zalutsky MR
    Clin Cancer Res; 1998 Oct; 4(10):2495-502. PubMed ID: 9796983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.
    Zalutsky MR; Archer GE; Garg PK; Batra SK; Bigner DD
    Nucl Med Biol; 1996 May; 23(4):449-58. PubMed ID: 8832699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.